Related Experiment Videos
Nucleic acid metabolism disturbance in progressive systemic sclerosis (systemic scleroderma)
Clinica Chimica Acta; International Journal of Clinical Chemistry
|December 1, 1978
Summary
This study found increased plasma DNA and decreased RNA in progressive systemic sclerosis (PSS) patients. Treatment normalized these nucleic acid levels, linking DNA to disease activity and RNA to its progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Clinical Medicine
Background:
- Progressive systemic sclerosis (PSS) is an autoimmune disease with complex pathophysiology.
- Nucleic acid (NA) metabolism may be altered in various disease states.
Purpose of the Study:
- To investigate the levels of helical RNA and DNA in the plasma of patients with PSS.
- To explore the correlation between these nucleic acid levels and disease activity or progression.
Main Methods:
- Quantification of helical RNA and DNA content in plasma samples from 28 PSS patients.
- Analysis of nucleic acid levels in relation to disease activity and disease course.
Main Results:
- Elevated plasma DNA levels and decreased plasma RNA levels were observed in PSS patients compared to controls.
- A normalization of these nucleic acid levels was noted during treatment.
- Plasma DNA content correlated with the activity of the disease process.
- Plasma RNA content correlated with the overall course of the disease.
Conclusions:
- Disturbances in nucleic acid metabolism are present in PSS patients.
- Plasma nucleic acid levels may serve as potential biomarkers for PSS activity and progression.